Analysts Set Cryoport, Inc. (NASDAQ:CYRX) Price Target at $12.29

Cryoport, Inc. (NASDAQ:CYRX) has been assigned an average rating of “Moderate Buy” from the seven brokerages that are presently covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $12.29.

Several research firms recently weighed in on CYRX. Needham & Company LLC reiterated a “buy” rating and set a $11.00 target price on shares of Cryoport in a research report on Friday, January 17th. Guggenheim began coverage on Cryoport in a research report on Thursday, December 19th. They set a “buy” rating and a $11.00 target price on the stock. Finally, Roth Mkm lowered their target price on Cryoport from $18.00 to $15.00 and set a “buy” rating on the stock in a research report on Friday, November 8th.

Insider Activity

In other news, CEO Jerrell Shelton sold 50,000 shares of the business’s stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $6.51, for a total value of $325,500.00. Following the transaction, the chief executive officer now directly owns 731,897 shares in the company, valued at $4,764,649.47. The trade was a 6.39 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Ramkumar Mandalam sold 7,369 shares of the business’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $7.46, for a total value of $54,972.74. Following the completion of the transaction, the director now owns 59,497 shares in the company, valued at $443,847.62. The trade was a 11.02 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 59,869 shares of company stock worth $396,673 over the last ninety days. Corporate insiders own 10.10% of the company’s stock.

Institutional Investors Weigh In On Cryoport

Large investors have recently made changes to their positions in the company. Point72 Asia Singapore Pte. Ltd. increased its holdings in shares of Cryoport by 148.7% in the fourth quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,546 shares of the company’s stock worth $28,000 after purchasing an additional 2,120 shares during the last quarter. Lazard Asset Management LLC bought a new stake in shares of Cryoport in the fourth quarter worth about $51,000. Avanza Fonder AB bought a new stake in shares of Cryoport in the fourth quarter worth about $64,000. Quarry LP bought a new stake in shares of Cryoport in the fourth quarter worth about $69,000. Finally, Dynamic Technology Lab Private Ltd bought a new stake in shares of Cryoport in the third quarter worth about $82,000. 92.90% of the stock is owned by institutional investors.

Cryoport Stock Performance

CYRX stock opened at $6.77 on Friday. The company has a market cap of $334.64 million, a P/E ratio of -2.00 and a beta of 1.59. The company has a debt-to-equity ratio of 0.48, a current ratio of 5.70 and a quick ratio of 5.32. The stock’s fifty day moving average price is $7.72 and its 200-day moving average price is $7.78. Cryoport has a 1 year low of $5.32 and a 1 year high of $20.10.

About Cryoport

Cryoport, Inc provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services.